Measuring treatment outcomes in women with vulvodynia.
Gary Ventolini
https://pubmed.ncbi.nlm.nih.gov/21811531/Actively Recruiting
Led by Texas Tech University Health Sciences Center · Updated on 2025-12-18
550
Participants Needed
1
Research Sites
21 weeks
Total Duration
This research aims to understand the role of unusual proteins, cytokines, and vaginal microbial flora in causing vulvodynia, recurrent fungal and bacterial vaginosis, and preterm labor. The study compares these factors in different groups of women to uncover how changes in the vaginal environment might lead to symptoms like irritation, pain, and infection recurrence, as well as premature birth. Researchers will use a multidisciplinary approach involving microbiology, proteomics, and cytokine analysis to explore these mechanisms. Participants include four groups of women aged 21 to 75 years healthy non-pregnant women without a history of vulvovaginal conditions, non-pregnant women with vulvovaginal issues, healthy pregnant women, and pregnant women with vulvovaginal conditions. Vaginal samples will be collected using cotton swabs from the middle vagina, processed for microbiological and biochemical testing including cytokine and protein levels. Pregnant women will have samples collected up to four times over 12 months. During the study, participants will provide informed consent and complete a comprehensive history related to environmental factors and vulvovaginal health. Researchers will measure cytokines, proteins, and vaginal lactobacillus levels from collected samples. Data will be kept confidential and stored securely. The main outcome is cytokine determination, with secondary outcomes including protein and lactobacillus analysis. The study aims to create a data bank to support future research, with participation lasting according to sample collection schedules.
CONDITIONS
Prospective Data Bank Creation to Study Vaginal Conditions
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Texas Tech University Health Sciences Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - One-time procedure
Participants undergo pelvic examination to obtain vaginal swab samples for proteomics, cytokines, and microbiological analysis.
1 visit (in-person)
Duration - Up to 12 months
Pregnant participants have follow-up sample collections up to 4 times over 12 months to evaluate changes in vaginal milieu during pregnancy.
Up to 4 visits (in-person) for pregnant participants; no additional visits for non-pregnant participants
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Gary Ventolini
https://pubmed.ncbi.nlm.nih.gov/21811531/Hans Verstraelen, Rita Verhelst, Geert Claeys...
https://pubmed.ncbi.nlm.nih.gov/19490622/G Traisnel, J M Lablanche, J L Fourrier...
https://pubmed.ncbi.nlm.nih.gov/3144947/Gary Ventolini, Sheela M Barhan
https://pubmed.ncbi.nlm.nih.gov/18319019/Gary Ventolini
https://pubmed.ncbi.nlm.nih.gov/22951941/G Ventolini, S Barhan, J Duke
https://pubmed.ncbi.nlm.nih.gov/19757274/Sota Omoigui
https://pubmed.ncbi.nlm.nih.gov/17728071/Texas Tech University Health Sciences Center
Lead Sponsor